文献速递免疫规划传染病防控与疫情报告

母源中和抗体降低猪繁殖与呼吸综合征活疫苗效力

Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection.
PubMed 文献 · Vaccine · 2019-06-24

研究将低或高母源中和抗体(MDNA)仔猪接种PRRSV-1活疫苗并攻毒,发现低MDNA组病毒血症显著降低且传播率更低,而高MDNA组疫苗效力受损,可能与疫苗复制减少有关。

要点

  • 高MDNA水平降低活疫苗病毒复制和血清转化。
  • 低MDNA组攻毒后病毒血症降低100倍,传播率0.15。
  • IFNa水平可能干扰PRRSV疫苗接种效果。

核心结论

  • 母源中和抗体通过减少疫苗复制损害PRRSV活疫苗对接种猪和接触猪的效力。

研究设计与样本

  • 实验研究:从商业猪群选取低(A-)或高(A+)MDNA水平仔猪,3周龄接种PRRSV-1 MLV疫苗(V+)或不接种(V-),4周龄二次接种,5周后攻毒并混养接触猪。

主要发现

  • 接种后2周疫苗株检出率:A-V+组69%,A+V+组6%;接种后5周分别为50%和25%。
  • 接种后5周血清转化率:A-V+组94%,A+V+组44%,仅A-V+组诱导显著IFNg反应。
  • 攻毒后10天,A-V+组病毒血症较V-组低100倍,A+V+组无显著降低。
  • 估计传播率:A-V+组0.15 [0.07-0.29],A+V+组0.44 [0.18-1.76],V-组0.32 [0.14-0.68]。
  • 首次接种后疫苗株低检出与A-V+仔猪IFNa水平相关。

临床怎么用

  • 制定PRRSV免疫程序时应考虑仔猪母源中和抗体水平,高MDNA可能需调整接种策略。

局限性

  • 研究为实验条件,田间适用性需进一步验证;IFNa干扰机制为推测性关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Modified live virus (MLV) vaccines are commonly used to reduce the impact of porcine reproductive and respiratory syndrome (PRRS) but limited efficacy is achieved in field conditions. Here, we evaluated the impact of maternally-derived neutralizing antibodies (MDNAs) on vaccine efficacy after PRRS virus (PRRSV) challenge. Piglets with low (A-) or high (A+) MDNA levels derived from a commercial pig herd were moved to experimental facilities to be vaccinated (V+) or not (V-) with a PRRSV-1 MLV vaccine at 3 weeks of age (woa). Because of unexpectedly low vaccine detection in A-V+ piglets post-vaccination (pv), all V+ piglets received a second vaccination at 4 woa. Five weeks (W5) pv, piglets were inoculated with a PRRSV-1 field strain to evaluate vaccine protection, and were mingled 24 h later with non-inoculated piglets of similar immune status to assess viral transmission. Vaccine strain was detected at W2 pv in 69% and 6% of A-V+ and A+V+ piglets, and at W5 pv in 50% and 25% of A-V+ and A+V+ piglets, respectively. At W5 pv, 94% of A-V+ and 44% of A+V+ piglets seroconverted, with a significant IFNg response induction in the A-V+ group only. After challenge, compared to the V- inoculated group, viremia was 100-fold lower at 10 days post-infection in A-V+ whereas viremia was not significantly reduced in A+V+ piglets. A lower transmission rate was estimated for the A-V+ group: 0.15 [0.07-0.29] versus 0.44 [0.18-1.76] and 0.32 [0.14-0.68] for the A+V+ and V- groups, respectively. Investigations about the low vaccine strain detection after the first vaccination suggested a relationship between IFNa levels and vaccine strain detection in A-V+ piglets. We showed that MDNAs impair vaccine efficacy against PRRSV both in inoculated and contact piglets, probably by reducing vaccine replication. IFNa may also interfere with PRRSV vaccination. These new data could help improving vaccination protocols.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Renson P, Fablet C, Andraud M, et al. Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection. Vaccine. 2019. PMID: 31248683. doi:10.1016/j.vaccine.2019.06.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。